The privately owned IRBM Group today represents a diversified preclinical drug discovery company that provides integrated solutions from screening to preclinical candidate selection within the biotech and pharmaceutical sector.
September 17-20, 2017, Baveno, Italy IRBM will attend the SMASH – Small Molecular NMR Conference. Event Link...
19 luglio 2017
September 10-14, 2017, Paestum, Italy IRBM will attend the XXVI Congresso Nazionale della Società Chimica...